ECGenius
-
CathVision Appoints Eric Thepaut as Independent Chairman and Launches ECGenius® System v3.5
.
CathVision announced Eric Thepaut, former Boston Scientific EMEA President, as independent Chairman of the Board and launched ECGenius® System version 3.5. The upgraded system adds flexible interfacing, DICOM archiving, improved hardware for lower artefacts, and 12‑lead ECG capture, enhancing workflow and signal fidelity. With FDA clearance (2023) and CE marking (2025), the company aims to accelerate U.S. and European EP market entry, leveraging Thepaut’s experience to capture a growing $10 billion market and target $120 million in revenue within three years.
